Sofinnova Partners aims to invest in 50 to 60 new companies in the life sciences. The infusion of new capital brings the VC firm’s assets under management to more than €4 billion.
The Seattle-based company is one of several that have raised venture capital and equity investment funding this week.
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
A round-up of funding announcements this week. Other companies that have raised new venture capital funding rounds this week include Genespire, HeartVista and Particle Health and Vida.
The San Francisco-based startup is one of several that have been raising money over the past couple of weeks in areas like neurology, oncology and women's health.
The first HealthTech Investor Days conference takes place Monday and Tuesday. The event will bring together 100 late-stage companies with investors, pharma companies and others.
MedDay's new spate of U.S. trials follow the successful Phase 3 study in progressive multiple sclerosis in Europe.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The venture capital firm, looking to further expand its life sciences portfolio, has now brought the total amount under management to €1.5 billion ($1.6 billion).